233 related articles for article (PubMed ID: 5572915)
21. Monitoring myelomatosis.
Hobbs JR
Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
[TBL] [Abstract][Full Text] [Related]
22. Sequential therapy compared with combination therapy in multiple myeloma.
Arch Intern Med; 1975 Jan; 135(1):163-71. PubMed ID: 1111465
[TBL] [Abstract][Full Text] [Related]
23. [Thoracic manifestations in Kahler's disease (apopos of 3 cases)].
Pieron R; Fernet M; Cosset JM; Psalmon JF; Oustrieres G; Temkine J; Jagueux M; Mafart Y
Poumon Coeur; 1972; 28(8):427-33. PubMed ID: 4665351
[No Abstract] [Full Text] [Related]
24. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
[TBL] [Abstract][Full Text] [Related]
25. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
Br Med J; 1971 Mar; 1(5750):640-1. PubMed ID: 4926948
[TBL] [Abstract][Full Text] [Related]
26. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.
Carbone PP; Kellerhouse LE; Gehan EA
Am J Med; 1967 Jun; 42(6):937-48. PubMed ID: 6027163
[No Abstract] [Full Text] [Related]
27. Multiple myeloma without initial paraproteins.
Kim I; Harley JB; Weksler B
Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
[No Abstract] [Full Text] [Related]
28. [2 new cases of initial or secondarily non-excreting plasma cell myelomas].
Prost A; Soulilou JP; Gardais J; Hurez D; Cottin S
Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):151-7. PubMed ID: 4574504
[No Abstract] [Full Text] [Related]
29. [Benign and malignant monoclonal hypergammaglobulinemia (gammopathy)].
Waldenström J
Schweiz Med Wochenschr; 1970 Feb; 100(7):290-6. PubMed ID: 4189916
[No Abstract] [Full Text] [Related]
30. [Chemotherapy of malignant skeletal tumors (author's transl)].
Brunner KW; Wagner HP
Ther Umsch; 1979 Jul; 36(7):653-6. PubMed ID: 89708
[No Abstract] [Full Text] [Related]
31. [Biological criteria of Kahler's disease].
Delmas-Marsalet Y; Goudemand M
Cah Coll Med Hop Paris; 1969 Apr; 10(4):245-50. PubMed ID: 5398287
[No Abstract] [Full Text] [Related]
32. [Visceral calcinosis induced by intravenous phosphate perfusions in myelomatous hypercalcemia].
Deshayes P; Levillain D; Cauvin M; Forthomme J
Sem Hop; 1969 Feb; 45(7):444-9. PubMed ID: 4307115
[No Abstract] [Full Text] [Related]
33. A urinary cryo-Bence Jones protein gelling at room temperature.
Harris RI; Kohn J
Clin Chim Acta; 1974 Jun; 53(2):233-7. PubMed ID: 4841989
[No Abstract] [Full Text] [Related]
34. Melphalan therapy for plasma cell myeloma.
Alexanian R; Bergsagel DE; Migliore PJ; Vaughn WK; Howe CD
Blood; 1968 Jan; 31(1):1-10. PubMed ID: 5638562
[No Abstract] [Full Text] [Related]
35. The current status and future prospects of treatment for multiple myeloma.
Durie BG; Salmon SE
Clin Haematol; 1982 Feb; 11(1):181-210. PubMed ID: 6176381
[No Abstract] [Full Text] [Related]
36. Prognostic factors for multiple myeloma in the dog.
Matus RE; Leifer CE; MacEwen EG; Hurvitz AI
J Am Vet Med Assoc; 1986 Jun; 188(11):1288-92. PubMed ID: 3721983
[TBL] [Abstract][Full Text] [Related]
37. Cyclophosphamide vs melphalan in myeloma.
Bennett JM
JAMA; 1969 Apr; 208(3):536. PubMed ID: 5818538
[No Abstract] [Full Text] [Related]
38. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
Alexanian R; Migliore PJ
J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
[No Abstract] [Full Text] [Related]
39. [Hemorrhagic syndrome due to isolated Stuart factor deficiency during Kahler's disease with amylosis].
Pieron R; Fernet M; Vergoz D; Duhamel G; Jagueux M
Ann Med Interne (Paris); 1972; 123(8):765-70. PubMed ID: 4539330
[No Abstract] [Full Text] [Related]
40. Growth rates and responses to treatment in human myelomatosis.
Hobbs JR
Br J Haematol; 1969 Jun; 16(6):607-17. PubMed ID: 4184691
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
